Article 05 Nov 2024 Alvotech And Teva Announce FDA Approval Of Additional Presentation For Ustekinumab Biosimilar United States Healthcare
Article 29 Aug 2024 EMA Accepts Marketing Authorization Application For Alvotech's AVT06 (Aflibercept) France Healthcare
Article 23 Jul 2024 FTC Issues Interim Report On Ongoing Study Of Pharmacy Benefit Managers United States Healthcare
Article 15 Apr 2024 Janssen v. Teva: Not An April Fool's Day Joke For Life Sciences Companies United States IP
Article 11 Mar 2024 Artiva Biotherapeutics Receives FDA Fast Track Designation For AlloNK In Lupus Nephritis United States Healthcare
Article 06 Feb 2024 USPTO Publishes Enablement Guidelines In View Of Amgen v. Sanofi United States Healthcare